Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
RFK Jr. grilled on Medicare: What is Medicare Part A, Medicare Part B and Medicaid? What are they?
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
RFK Jr. second hearing takeaways: GOP criticism, more Medicare fumbles, and DEI
RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Cowboys QB Dak Prescott supports effort to get cancer test covered by Medicare
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
CNN on MSN14d
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Medicare spent $14.4 billion on Ozempic and Wegovy ... continuing to wind their way through district and appellate courts.
Nasdaq10d
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
The U.S. Food and Drug Administration (FDA ... See the 10 stocks » However, the Centers for Medicare and Medicaid Services (CMS) could soon throw a monkey wrench into Novo Nordisk's momentum.
Morningstar6d
Trump rolls back effort to lower Medicare, Medicaid drug costs
along with another program that would see Medicare pay less for drugs that receive accelerated approval from the Food and Drug Administration. The cell- and gene-therapy program, meanwhile ...